Bangladesh has launched an emergency measles-rubella vaccination campaign as it battles a severe outbreak that has claimed the lives of more than 100 children in less than a month.
Emergency vaccination drive underway
The government, in partnership with the World Health Organization, UNICEF and Gavi, has begun vaccinating children aged six months to five years in 18 high-risk districts. The campaign is expected to expand nationwide in phases from next month.
Rising cases and vulnerable children
Official data indicates over 900 confirmed measles cases among 7,500 suspected infections reported since March 15. Health experts have expressed concern over the rapid spread, particularly among infants who are not yet eligible for routine vaccination.
UNICEF representative Rana Flowers warned that the surge highlights critical immunity gaps, especially among under-vaccinated and zero-dose children.
Disease risks and prevention
Measles is a highly contagious airborne disease that causes fever, respiratory symptoms and skin rashes, and can lead to severe complications or death, particularly in young children. Health authorities stress that at least 95 per cent vaccination coverage is required to effectively prevent outbreaks.
Disruptions and policy concerns
Health Minister Sardar Mohammed Sakhawat Husain attributed the outbreak to vaccine shortages and mismanagement by previous administrations, including that of former Prime Minister Sheikh Hasina and the interim government led by Muhammad Yunus.
The country’s immunisation programmes were also disrupted during recent political unrest, affecting vaccine availability.
Public advisory issued
Doctors have urged parents to seek immediate medical care if children show symptoms such as high fever, warning against self-medication. Early treatment, officials say, can prevent complications and save lives.
Progress and persistent gaps
Despite significant progress since 1979, with immunisation coverage rising from 2 per cent to over 80 per cent, disparities remain. Health agencies stress the need for sustained efforts to ensure equitable vaccine access.
